238 related articles for article (PubMed ID: 30024108)
1. Cloaked Exosomes: Biocompatible, Durable, and Degradable Encapsulation.
Kumar S; Michael IJ; Park J; Granick S; Cho YK
Small; 2018 Aug; 14(34):e1802052. PubMed ID: 30024108
[TBL] [Abstract][Full Text] [Related]
2. Engineering exosomes as refined biological nanoplatforms for drug delivery.
Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
[TBL] [Abstract][Full Text] [Related]
3. One-Step Production Using a Microfluidic Device of Highly Biocompatible Size-Controlled Noncationic Exosome-like Nanoparticles for RNA Delivery.
Kimura N; Maeki M; Ishida A; Tani H; Tokeshi M
ACS Appl Bio Mater; 2021 Feb; 4(2):1783-1793. PubMed ID: 35014524
[TBL] [Abstract][Full Text] [Related]
4. Field-Free Isolation of Exosomes from Extracellular Vesicles by Microfluidic Viscoelastic Flows.
Liu C; Guo J; Tian F; Yang N; Yan F; Ding Y; Wei J; Hu G; Nie G; Sun J
ACS Nano; 2017 Jul; 11(7):6968-6976. PubMed ID: 28679045
[TBL] [Abstract][Full Text] [Related]
5. Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells.
Wang J; Li W; Zhang L; Ban L; Chen P; Du W; Feng X; Liu BF
ACS Appl Mater Interfaces; 2017 Aug; 9(33):27441-27452. PubMed ID: 28762264
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
[TBL] [Abstract][Full Text] [Related]
7. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
8. Post isolation modification of exosomes for nanomedicine applications.
Hood JL
Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
[TBL] [Abstract][Full Text] [Related]
9. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
[TBL] [Abstract][Full Text] [Related]
11. Exosome-like Nanovectors for Drug Delivery in Cancer.
Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
[TBL] [Abstract][Full Text] [Related]
12. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
[TBL] [Abstract][Full Text] [Related]
13. Exosomes as Theranostics for Lung Cancer.
Srivastava A; Amreddy N; Razaq M; Towner R; Zhao YD; Ahmed RA; Munshi A; Ramesh R
Adv Cancer Res; 2018; 139():1-33. PubMed ID: 29941101
[TBL] [Abstract][Full Text] [Related]
14. Exosome vesicle as a nano-therapeutic carrier for breast cancer.
Mughees M; Kumar K; Wajid S
J Drug Target; 2021 Feb; 29(2):121-130. PubMed ID: 32787592
[TBL] [Abstract][Full Text] [Related]
15. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.
Qi H; Liu C; Long L; Ren Y; Zhang S; Chang X; Qian X; Jia H; Zhao J; Sun J; Hou X; Yuan X; Kang C
ACS Nano; 2016 Mar; 10(3):3323-33. PubMed ID: 26938862
[TBL] [Abstract][Full Text] [Related]
16. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
17. Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer.
Jiang L; Gu Y; Du Y; Liu J
Mol Pharm; 2019 Aug; 16(8):3333-3349. PubMed ID: 31241965
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
19. Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers.
Yerneni SS; Lathwal S; Shrestha P; Shirwan H; Matyjaszewski K; Weiss L; Yolcu ES; Campbell PG; Das SR
ACS Nano; 2019 Sep; 13(9):10555-10565. PubMed ID: 31436946
[TBL] [Abstract][Full Text] [Related]
20. High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles.
Longatti A; Schindler C; Collinson A; Jenkinson L; Matthews C; Fitzpatrick L; Blundy M; Minter R; Vaughan T; Shaw M; Tigue N
Nanoscale; 2018 Aug; 10(29):14230-14244. PubMed ID: 30010165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
